High-Throughput Screening Platform To Identify Inhibitors of Protein Synthesis with Potential for the Treatment of Malaria
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-Throughput Screening Platform To Identify Inhibitors of Protein Synthesis with Potential for the Treatment of Malaria
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
American Society for Microbiology
Online
2022-06-01
DOI
10.1128/aac.00237-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box
- (2021) Janette Reader et al. Nature Communications
- Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study
- (2021) James S McCarthy et al. LANCET INFECTIOUS DISEASES
- Cellular thermal shift assay for the identification of drug–target interactions in the Plasmodium falciparum proteome
- (2020) Jerzy Michal Dziekan et al. Nature Protocols
- Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda
- (2020) Aline Uwimana et al. NATURE MEDICINE
- The antimalarial resistome – finding new drug targets and their modes of action
- (2020) Krypton Carolino et al. CURRENT OPINION IN MICROBIOLOGY
- Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
- (2019) Beatriz Baragaña et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
- (2019) Susan Wyllie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum
- (2019) Leila S. Ross et al. Cell Host & Microbe
- The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials
- (2018) Christine Moore Sheridan et al. MALARIA JOURNAL
- Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
- (2018) Victoriano Corpas-Lopez et al. ACS Infectious Diseases
- Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations
- (2017) Holly Matthews et al. PLoS One
- Antimalarial Drug Resistance: A Threat to Malaria Elimination
- (2017) Didier Menard et al. Cold Spring Harbor Perspectives in Medicine
- Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
- (2016) Beatriz Baragaña et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Plasmodium falciparum specific translation inhibitors from the MMV Malaria Box using a high throughput in vitro translation screen
- (2016) Vida Ahyong et al. MALARIA JOURNAL
- Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
- (2016) Nobutaka Kato et al. NATURE
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- A novel multiple-stage antimalarial agent that inhibits protein synthesis
- (2015) Beatriz Baragaña et al. NATURE
- Nitazoxanide: A first-in-class broad-spectrum antiviral agent
- (2014) Jean-François Rossignol ANTIVIRAL RESEARCH
- Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo
- (2014) Eva Maria Novoa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetine
- (2014) Wilson Wong et al. eLife
- New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species
- (2013) Karel Pauk et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Substituted 2-Phenylimidazopyridines: A New Class of Drug Leads for Human African Trypanosomiasis
- (2013) Hari Babu Tatipaka et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling
- (2012) Ill-Young Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Selective and Specific Inhibition of the Plasmodium falciparum Lysyl-tRNA Synthetase by the Fungal Secondary Metabolite Cladosporin
- (2012) Dominic Hoepfner et al. Cell Host & Microbe
- Borrelidin, a Potent Antifungal Agent: Insight into the Antifungal Mechanism against Phytophthora sojae
- (2012) Ya-Mei Gao et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
- (2012) Tracy L Keller et al. Nature Chemical Biology
- Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia
- (2011) Darya Habibi et al. INVESTIGATIONAL NEW DRUGS
- Thousands of chemical starting points for antimalarial lead identification
- (2010) Francisco-Javier Gamo et al. NATURE
- Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin
- (2010) Tilman Schneider-Poetsch et al. Nature Chemical Biology
- In Pursuit of Natural Product Leads: Synthesis and Biological Evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4-carboxylic acid (A-33853) and Its Analogues: Discovery ofN-(2-Benzoxazol-2-ylphenyl)benzamides as Novel Antileishmanial Chemotypes
- (2008) Suresh K. Tipparaju et al. JOURNAL OF MEDICINAL CHEMISTRY
- Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics
- (2008) Erica L. Dahl et al. TRENDS IN PARASITOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More